SRINIVAS AKKARAJU
CIK 1253170 · last filed 2026-06-08
SRINIVAS AKKARAJU is a corporate insider who has filed 187 SEC Form 4 insider transactions across 22 companies since 2007. The most recent filing, for SRRK, was dated Jun 8, 2026. Across all open-market trades the lifetime net is +$171.9M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $304.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$304.64M
22
187
$171.88M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SRRK | Director | 558,009 | $44.18 | $24.65M | $603.3K | 9 | 2026-06-08 |
| KLRS | Director | 19,408 | $4.33 | $84.0K | $5.90M | 3 | 2026-06-04 |
| MLYS | Director | 5,877,218 | $23.62 | $138.82M | $53.10M | 8 | 2026-02-20 |
| ALMS | Director | 4,491,731 | $24.15 | $108.48M | $45.55M | 12 | 2026-01-13 |
| VTVT | Director | 106,000 | $32.77 | $3.47M | $0 | 7 | 2025-09-25 |
| Kalaris Therapeutics, Inc. (ALVR) Delisted | Director | 11,444,503 | $9.81 | $112.27M | $0 | 1 | 2025-03-18 |
| SYRS | Director | 1,795,760 | $0.00 | $718 | $7.14M | 22 | 2024-09-18 |
| CARGO Therapeutics, Inc. (CRGX) Delisted | 10%+ Owner | 4,415,689 | $4.47 | $19.74M | $14.99M | 1 | 2024-06-03 |
| CHINOOK THERAPEUTICS, INC. (KDNY) Delisted | Director | 0 | $40.39 | $0 | $27.49M | 8 | 2023-08-11 |
| INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Director | 686,686 | $19.00 | $13.05M | $16.76M | 33 | 2023-05-25 |
| LENZ Therapeutics, Inc. (GRPH) Delisted | 10%+ Owner | 37,753 | $22.26 | $840.4K | $455.1K | 1 | 2021-12-20 |
| Jiya Acquisition Corp. (JYAC) Delisted | Director | 507,041 | $10.04 | $5.09M | $0 | 2 | 2021-08-30 |
| Seagen Inc. (SGEN) Delisted | Director | 2,183,433 | $228.74 | $499.44M | -$30.51M | 36 | 2020-05-19 |
| Aravive, Inc. (ARAV) Delisted | Director | 607,881 | $0.04 | $24.4K | $1000.0K | 4 | 2019-12-02 |
| Principia Biopharma Inc. (PRNB) Delisted | Director | 208,480 | — | — | $2.98M | 2 | 2019-01-10 |
| Aravive, Inc. (VSAR) Delisted | Director | 474,548 | — | — | $25.70M | 12 | 2018-10-16 |
| LIFE | Director | 1,866,126 | $15.61 | $29.13M | $4.48M | 5 | 2017-05-11 |
| SYNLOGIC, INC. (MIRN) Delisted | 10%+ Owner | 2,974,811 | — | — | $30.00M | 1 | 2015-10-06 |
| ZS Pharma, Inc. (ZSPH) Delisted | Director | — | — | — | $0 | 2 | 2015-06-29 |
| SYNAGEVA BIOPHARMA CORP (GEVA) Delisted | Director | 1,340,283 | — | — | -$24.74M | 4 | 2012-06-28 |
| PHARMOS CORP (PARS) Delisted | Director | 2,845,160 | — | — | $0 | 4 | 2009-01-27 |
| BARRIER THERAPEUTICS INC (BTRX) Delisted | Director | 46,312 | — | — | -$9.01M | 2 | 2007-06-08 |
Recent Filings
187 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-08 | SRRK | Grant (A) | +6,839 | $0 | EDGAR |
| 2026-06-04 | KLRS | Grant (A) | — | $0 | EDGAR |
| 2026-05-22 | KLRS | Mixed | +984,010 | $5.90M | EDGAR |
| 2026-02-20 | MLYS | Grant (A) | +6,200 | $0 | EDGAR |
| 2026-01-13 | ALMS | Buy (P) | +588,235 | $10.00M | EDGAR |
| 2025-12-16 | SRRK | Mixed | +1,094,403 | $9.01M | EDGAR |
| 2025-12-09 | ALMS | Buy (P) | +186,377 | $1.83M | EDGAR |
| 2025-12-04 | ALMS | Buy (P) | +262,027 | $2.04M | EDGAR |
| 2025-12-01 | ALMS | Buy (P) | +173,589 | $1.31M | EDGAR |
| 2025-11-24 | ALMS | Buy (P) | +125,743 | $905.3K | EDGAR |